Utama › Neuroblastoma › Alabama
Kajian klinikal Neuroblastoma di Alabama
8 kajian untuk Neuroblastoma sedang mencari peserta di lokasi di Alabama.
Bandar di Alabama
Teks kajian rasmi (Bahasa Inggeris)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Children's Hospital of Alabama, Birmingham
- USA Health Strada Patient Care Center, Mobile
Mengambil pesertaFasa 3
Sehingga umur 30 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06172296Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- University of Alabama/Children's of Alabama, Birmingham
Mengambil pesertaFasa 2
Sehingga umur 22 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT02559778Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- University of Alabama/Children's of Alabama, Birmingham
Mengambil pesertaFasa 1/2
Sehingga umur 26 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- University of Alabama/Children's of Alabama, Birmingham
Mengambil pesertaFasa 1/2
Sehingga umur 30 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06541262Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Children's Hospital of Alabama, Birmingham
Mengambil pesertaFasa 3
365 Days – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Alabama, Birmingham
Mengambil pesertaFasa 1/2
12 Months – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04851119Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- University of Alabama/Children's of Alabama, Birmingham
Mengambil pesertaFasa 2
12 Months – 21 Years · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT05489887A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital of Alabama/UAB, Birmingham
Mengambil pesertaFasa 2
18 Months – 40 Years · Semua jantina · Dikemas kini 12 Ogo 2025 · NCT05135975Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.